Table of contents
Volume 94, Issue 6
Published online 21 March 2006 (771-940)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letters to the Editor |
Corrigendum
Minireviews
Crosstalk between the EGFR and other signalling pathways at the level of the global transcriptional corepressor Groucho/TLE FREE
P Hasson and Z Paroush
Br J Cancer 94: 771-775; advance online publication, February 28, 2006; doi:10.1038/sj.bjc.6603019
MicroRNAs in cell proliferation, cell death, and tumorigenesis FREE
H-W Hwang and J T Mendell
Br J Cancer 94: 776-780; advance online publication, February 21, 2006; doi:10.1038/sj.bjc.6603023
Clinical Studies
The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer FREE
G W A Lamb, D C McMillan, S Ramsey and M Aitchison
Br J Cancer 94: 781-784; advance online publication, March 7, 2006; doi:10.1038/sj.bjc.6603034
Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer FREE
M Reni, L Pasetto, G Aprile, S Cordio, E Bonetto, S Dell'oro, P Passoni, L Piemonti, C Fugazza, G Luppi, C Milandri, R Nicoletti, A Zerbi, G Balzano, V Di Carlo and A A Brandes
Br J Cancer 94: 785-791; advance online publication, February 28, 2006; doi:10.1038/sj.bjc.6603026
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial FREE
B Vincenzi, D Santini, C Rabitti, R Coppola, B Beomonte Zobel, L Trodella and G Tonini
Br J Cancer 94: 792-797; advance online publication, February 28, 2006; doi:10.1038/sj.bjc.6603018
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG) FREE
J Souglakos, N Androulakis, K Syrigos, A Polyzos, N Ziras, A Athanasiadis, S Kakolyris, S Tsousis, Ch Kouroussis, L Vamvakas, A Kalykaki, G Samonis, D Mavroudis and V Georgoulias
Br J Cancer 94: 798-805; advance online publication, February 28, 2006; doi:10.1038/sj.bjc.6603011
A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma FREE
C Burton, D Linch, P Hoskin, D Milligan, M J S Dyer, B Hancock, P Mouncey, P Smith, W Qian, K MacLennan, A Jack, A Webb and D Cunningham
Br J Cancer 94: 806-813; advance online publication, February 28, 2006; doi:10.1038/sj.bjc.6602975
Surveillance of women at high risk for hereditary ovarian cancer is inefficient FREE
A L Oei, L F Massuger, J Bulten, M J Ligtenberg, N Hoogerbrugge and J A de Hullu
Br J Cancer 94: 814-819; advance online publication, February 21, 2006; doi:10.1038/sj.bjc.6603015
Late recurrences of germ cell malignancies: a population-based experience over three decades FREE
J Oldenburg, G C Alfsen, H Wæhre and S D Fosså
Br J Cancer 94: 820-827; advance online publication, February 28, 2006; doi:10.1038/sj.bjc.6603014
A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer FREE
V Jenkins, V Shilling, G Deutsch, D Bloomfield, R Morris, S Allan, H Bishop, N Hodson, S Mitra, G Sadler, E Shah, R Stein, S Whitehead and J Winstanley
Br J Cancer 94: 828-834; advance online publication, March 7, 2006; doi:10.1038/sj.bjc.6603029
Metallothionein – overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients FREE
G Weinlich, K Eisendle, E Hassler, M Baltaci, P O Fritsch and B Zelger
Br J Cancer 94: 835-841; advance online publication, February 28, 2006; doi:10.1038/sj.bjc.6603028
Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs FREE
M D Brown, C A Hart, E Gazi, S Bagley and N W Clarke
Br J Cancer 94: 842-853; advance online publication, March 7, 2006; doi:10.1038/sj.bjc.6603030
Translational Therapeutics
Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase FREE
F Okada, H Shionoya, M Kobayashi, T Kobayashi, H Tazawa, K Onuma, Y Iuchi, N Matsubara, T Ijichi, B Dugas and M Hosokawa
Br J Cancer 94: 854-862; advance online publication, February 28, 2006; doi:10.1038/sj.bjc.6603016
Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration FREE
C M Lee and I F Tannock
Br J Cancer 94: 863-869; advance online publication, February 21, 2006; doi:10.1038/sj.bjc.6603010
Molecular Diagnostics
hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cells FREE
J T Chang, Y-C Lu, Y-J Chen, C-P Tseng, Y-L Chen, C-W Fang and A-J Cheng
Br J Cancer 94: 870-878; advance online publication, February 28, 2006; doi:10.1038/sj.bjc.6603008
Mycosis fungoides: is it a Borrelia burgdorferi-associated disease? FREE
S Miertusova Tothova, S Bonin, G Trevisan and G Stanta
Br J Cancer 94: 879-883; advance online publication, February 21, 2006; doi:10.1038/sj.bjc.6602997
Cellular changes in boric acid-treated DU-145 prostate cancer cells FREE
W T Barranco and C D Eckhert
Br J Cancer 94: 884-890; advance online publication, February 21, 2006; doi:10.1038/sj.bjc.6603009
Fluorescence in-situ hybridisation on biopsies from clam ileocystoplasties and on a clam cancer FREE
K D Ivil, S H Doak, S A Jenkins, E M Parry, H G Kynaston, J M Parry and T P Stephenson
Br J Cancer 94: 891-895; doi:10.1038/sj.bjc.6603035
Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking FREE
K Sugio, H Uramoto, K Ono, T Oyama, T Hanagiri, M Sugaya, Y Ichiki, T So, S Nakata, M Morita and K Yasumoto
Br J Cancer 94: 896-903; doi:10.1038/sj.bjc.6603040
A distinct molecular profile associated with mucinous epithelial ovarian cancer FREE
V A Heinzelmann-Schwarz, M Gardiner-Garden, S M Henshall, J P Scurry, R A Scolyer, A N Smith, A Bali, P Vanden Bergh, S Baron-Hay, C Scott, D Fink, N F Hacker, R L Sutherland and P M O'Brien
Br J Cancer 94: 904-913; advance online publication, February 28, 2006; doi:10.1038/sj.bjc.6603003
Genetics and Genomics
Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines FREE
K Terasawa, M Toyota, S Sagae, K Ogi, H Suzuki, T Sonoda, K Akino, R Maruyama, N Nishikawa, K Imai, Y Shinomura, T Saito and T Tokino
Br J Cancer 94: 914-921; advance online publication, February 14, 2006; doi:10.1038/sj.bjc.6602984
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas FREE
G M Caldwell, C E Jones, P Taniere, R Warrack, Y Soon, G M Matthews and D G Morton
Br J Cancer 94: 922-927; advance online publication, March 7, 2006; doi:10.1038/sj.bjc.6602967
Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma FREE
E S Schernhammer, G J Tranah, E Giovannucci, A T Chan, J Ma, G A Colditz, D J Hunter, W C Willett and C S Fuchs
Br J Cancer 94: 928-934; advance online publication, February 21, 2006; doi:10.1038/sj.bjc.6603007
Letters to the Editor
Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan FREE
C Alliot
Br J Cancer 94: 935-936; advance online publication, February 21, 2006; doi:10.1038/sj.bjc.6603021
Reply: Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan FREE
G Chong and D Cunningham on behalf of the authors
Br J Cancer 94: 937; advance online publication, February 21, 2006; doi:10.1038/sj.bjc.6603022
Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? FREE
C Alliot
Br J Cancer 94: 938-939; advance online publication, March 7, 2006; doi:10.1038/sj.bjc.6603032
Corrigendum
Magnetic field exposure and long-term survival among children with leukaemia FREE
D E Foliart, B H Pollock, G Mezei, R Iriye, J M Silva, K L Ebi, L Kheifets, M P Link and R Kavet
Br J Cancer 94: 940; doi:10.1038/sj.bjc.6603002
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
